China SXT Pharmaceuticals, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2025-03-31 | $2.10M 20-F · filed 2026-07-01 | |
| 2024-03-31 | $2.81M 20-F · filed 2026-07-01 | |
| 2023-03-31 | $2.95M 20-F · filed 2023-07-31 | |
| 2021-03-31 | $7.68M 20-F · filed 2023-07-31 | |
| 2020-03-31 | $6.43M 20-F/A · filed 2023-05-19 |